FOCUS Investment Banking Represents Clinart in its Acquisition by Greater Cincinnati-based CTI Clinical Trial and Consulting Services

2024-02-12T23:33:19+00:00Healthcare, Life Sciences, Mergers & Acquisitions News, Mergers, Acquisitions & Divestitures|

FOCUS Investment Banking (“FOCUS”), a Washington DC-based investment bank, represented Clinart, a regional CRO (Contract Research Organization) located in Dubai, in its acquisition by CTI, Clinical Trial and Consulting Services, an international CRO headquartered in Cincinnati, Ohio.

White Paper: Private Equity Investment in Ophthalmology – August 2020 State of the Market

2024-01-22T11:00:20+00:00Downloads, Healthcare, White Papers|

A comprehensive view of ophthalmology's recovery from the pandemic shutdown. We review changes in elective surgery, the emerging investor interest in retina practices, private  equity acquisition activity, geographic development, and changes to acquisition practice size. As the COVID-19 fog begins to clear, we see significant near-term promise and a potential return to record deal levels.

Go to Top